Speaking on the occasion Nagendra Vittal, Chairman Austrak Pvt Ltd said, “Quality is the prime focus at Austrak. All our products are manufactured in WHO/GMP standard manufacturing plants and all facilities meet CGMP standards. In line with our ambitious growth plans, we are launching our nephrology and urology division today. This division focuses on around 73 valued products in the segment. Our aim is to develop & market high quality specialty, therapeutic & medical products to cure critical illnesses like chronic kidney disease (CKD) and urology related ailments with their high prevalence, morbidity and mortality & ease sufferings.”
The company’s aim is to develop & market high quality specialty, therapeutic & medical products to cure critical illnesses & ease sufferings. Large numbers of patients below the poverty line, low gross domestic product, and low monetary allocations for healthcare have led to suboptimal outcomes. Moreover, CKD, urinary problems and other non-communicable diseases have often been ignored in the face of persistent challenges due to competition for resources of communicable diseases and high infant and maternal mortality.